Protein Arginine Deiminase 4: a Target for an Epigenetic Cancer Therapy

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2010 Aug 14

PMID 20706768

Citations 57

Authors

Jessica L Slack

Corey P Causey

Paul R Thompson

Affiliations

Soon will be listed here.

Abstract

The recent approvals of anticancer therapeutic agents targeting the histone deacetylases and DNA methyltransferases have highlighted the important role that epigenetics plays in human diseases, and suggested that the factors controlling gene expression are novel drug targets. Protein arginine deiminase 4 (PAD4) is one such target because its effects on gene expression parallel those observed for the histone deacetylases. We demonstrated that F- and Cl-amidine, two potent PAD4 inhibitors, display micromolar cytotoxic effects towards several cancerous cell lines (HL-60, MCF7 and HT-29); no effect was observed in noncancerous lines (NIH 3T3 and HL-60 granulocytes). These compounds also induced the differentiation of HL-60 and HT29 cells. Finally, these compounds synergistically potentiated the cell killing effects of doxorubicin. Taken together, these findings suggest PAD4 inhibition as a novel epigenetic approach for the treatment of cancer, and suggest that F- and Cl-amidine are candidate therapeutic agents for this disease.

Citing Articles

Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases.

Yao W, Hu X, Wang X Signal Transduct Target Ther. 2024; 9(1):232.

PMID: 39278916 PMC: 11403012. DOI: 10.1038/s41392-024-01918-w.

The Role of Citrullination Modification in CD4 T Cells in the Pathogenesis of Immune-Related Diseases.

Chen Y, Teng Y, Xu P, Wang S Biomolecules. 2024; 14(4).

PMID: 38672418 PMC: 11047979. DOI: 10.3390/biom14040400.

The investigation of cytotoxic and apoptotic activity of Cl-amidine on the human U-87 MG glioma cell line.

Oguten P, Engur Ozturk S, Dikmen M Medicine (Baltimore). 2024; 103(8):e37015.

PMID: 38394536 PMC: 11309612. DOI: 10.1097/MD.0000000000037015.

Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.

Wang Y, Song X, Song Y, Fang K, Chang X J Cancer Res Clin Oncol. 2023; 149(19):17253-17268.

PMID: 37804426 PMC: 10657297. DOI: 10.1007/s00432-023-05433-3.

Epigenetic meets metabolism: novel vulnerabilities to fight cancer.

Scumaci D, Zheng Q Cell Commun Signal. 2023; 21(1):249.

PMID: 37735413 PMC: 10512595. DOI: 10.1186/s12964-023-01253-7.

References

Zeng Y, El-Deiry W . Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene. 1996; 12(7):1557-64. View

Cuthbert G, Daujat S, Snowden A, Erdjument-Bromage H, Hagiwara T, Yamada M . Histone deimination antagonizes arginine methylation. Cell. 2004; 118(5):545-53. DOI: 10.1016/j.cell.2004.08.020. View

Chang X, Han J . Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol Carcinog. 2005; 45(3):183-96. DOI: 10.1002/mc.20169. View

Maragoudakis M, Tsopanoglou N, Andriopoulou P . Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans. 2002; 30(2):173-7. DOI: 10.1042/. View

Jonsson E, Fridborg H, Nygren P, Larsson R . Synergistic interactions of combinations of topotecan with standard drugs in primary cultures of human tumor cells from patients. Eur J Clin Pharmacol. 1998; 54(7):509-14. DOI: 10.1007/s002280050505. View

Kim M, Blake M, Baek J, Kohlhagen G, Pommier Y, Carrier F . Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res. 2003; 63(21):7291-300. View

Li P, Yao H, Zhang Z, Li M, Luo Y, Thompson P . Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol. 2008; 28(15):4745-58. PMC: 2493360. DOI: 10.1128/MCB.01747-07. View

Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T . The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001; 166(6):4177-84. DOI: 10.4049/jimmunol.166.6.4177. View

Wang Y, Li M, Stadler S, Correll S, Li P, Wang D . Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 2009; 184(2):205-13. PMC: 2654299. DOI: 10.1083/jcb.200806072. View

10.

Savoysky E, Yoshida K, Ohtomo T, Yamaguchi Y, Akamatsu K, Yamazaki T . Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. Biochem Biophys Res Commun. 1996; 226(2):329-34. DOI: 10.1006/bbrc.1996.1356. View

11.

Shankar S, Singh T, Fandy T, Luetrakul T, Ross D, Srivastava R . Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways. Int J Mol Med. 2005; 16(6):1125-38. View

12.

Barnard J, Warwick G . Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ. 1993; 4(6):495-501. View

13.

Marks P . The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA). Cell Cycle. 2004; 3(5):534-5. DOI: 10.4161/cc.3.5.827. View

14.

Yamada M, Mori M, Sugimura T . Purification and characterization of small molecular weight myeloperoxidase from human promyelocytic leukemia HL-60 cells. Biochemistry. 1981; 20(4):766-71. DOI: 10.1021/bi00507a018. View

15.

Causey C, Thompson P . An improved synthesis of haloaceteamidine-based inactivators of protein arginine deiminase 4 (PAD4). Tetrahedron Lett. 2009; 49(28):4383-4385. PMC: 2597826. DOI: 10.1016/j.tetlet.2008.05.021. View

16.

Yao H, Li P, Venters B, Zheng S, Thompson P, Pugh B . Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem. 2008; 283(29):20060-8. PMC: 2459274. DOI: 10.1074/jbc.M802940200. View

17.

Jiang H, Congleton J, Liu Q, Merchant P, Malavasi F, Lee H . Mechanism-based small molecule probes for labeling CD38 on live cells. J Am Chem Soc. 2009; 131(5):1658-9. PMC: 2644825. DOI: 10.1021/ja808387g. View

18.

Fischle W, Wang Y, Allis C . Binary switches and modification cassettes in histone biology and beyond. Nature. 2003; 425(6957):475-9. DOI: 10.1038/nature02017. View

19.

Valeriote F, Lin H . Synergistic interaction of anticancer agents: a cellular perspective. Cancer Chemother Rep. 1975; 59(5):895-900. View

20.

Luo Y, Knuckley B, Bhatia M, Pellechia P, Thompson P . Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe. J Am Chem Soc. 2006; 128(45):14468-9. PMC: 2234596. DOI: 10.1021/ja0656907. View